Follicular neoplasms of the thyroid: What to recommend

Thyroid

Volumn 15, Issue 6, 2005, Pages 583-587

  Carling, Tobias ^a   Udelsman, Robert ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131;

ASPIRATION BIOPSY; CELL HYPERPLASIA; CONTROLLED STUDY; DOSE RESPONSE; FROZEN SECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ONCOCYTOMA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE; THYROID ADENOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROID TUMOR;

ADENOCARCINOMA, FOLLICULAR; ANTINEOPLASTIC PROTOCOLS; HUMANS; POSTOPERATIVE COMPLICATIONS; THYROID NEOPLASMS; TREATMENT OUTCOME;

EID: 22244457676     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2005.15.583     Document Type: Review

References (33)

1. Jossart GH, Clark OH 1994 Well-differentiated thyroid cancer. Curr Probl Surg 31:933-1012.
2. Carling T, Udelsman R 2004 Thyroid Tumors. In: De Vita Jr VT, Hellman S, Rosenberg SA (eds) Cancer: Principles & Practice of Oncology, 6th ed. Lippincott-Raven, Philadelphia, (in press).
3. Li Volsi VA, Asa SL 1994 The demise of follicular carcinoma of the thyroid gland. Thyroid 4:233-236.
4. Correa P, Chen VW 1995 Endocrine gland cancer. Cancer 75:338-352.
5. Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, Schneider AB, Tucker MA, Boice JD Jr. 1995 Thyroid cancer after exposure to external radiation: A pooled analysis of seven studies. Radiat Res 141:259-277.
6. Shore RE, Woodard E, Hildreth N, Dvoretsky P, Hempelmann L, Pasternack B 1985 Thyroid tumors following thymus irradiation. J Natl Cancer Inst 74:1177-1184.
7. Schneider AB, Fogelfeld L 1997 Radiation-induced endocrine tumors. Cancer Treat Res 89:141-161.
8. Schneider AB, Ron E, Lubin J, Stovall M, Gierlowski TC 1993 Dose-response relationships for radiation-induced thyroid cancer and thyroid nodules: Evidence for the prolonged effects of radiation on the thyroid. J Clin Endocrinol Metab 77:362-369.
9. Ron E, Kleinerman RA, Boice JD, Jr, LiVolsi VA, Flannery JT, Fraumeni JF, Jr. 1987 A population-based case-control study of thyroid cancer. J Natl Cancer Inst 79:1-12.
10. Galanti MR, Ekbom A, Grimelius L, Yuen J 1997 Parental cancer and risk of papillary and follicular thyroid carcinoma. Br J Cancer 75:451-456.
11. Eng C 2000 Familial papillary thyroid cancer - Many syndromes, too many genes? J Clin Endocrinol Metab 85:1755-1757.
12. Malchoff CD, Malchoff DM 2002 The genetics of hereditary nonmedullary thyroid carcinoma. J Clin Endocrinol Metab 87:2455-2459.
13. Chen H, Nicol TL, Rosenthal DL, Udelsman R 1997 The role of fine-needle aspirations in the evaluation of thyroid nodules. Prob Gen Surg 14:1-13.
14. Frates MC, Benson CB, Doubilet PM, Cibas ES, Marqusee E 2003 Can color Doppler sonography aid in the prediction of malignancy of thyroid nodules? J Ultrasound Med 22:127-131; quiz 132-134.
15. Gharib H, Goellner JR, Johnson DA 1993 Fine-needle aspiration cytology of the thyroid. A 12-year experience with 11,000 biopsies. Clin Lab Med 13:699-709.
16. Chen H, Nicol TL, Udelsman R 1995 Follicular lesions of the thyroid. Does frozen section evaluation alter operative management? Ann Surg 222:101-106.
17. Udelsman R, Lakatos E, Ladenson P 1996 Optimal surgery for papillary thyroid carcinoma. World J Surg 20:88-93.
18. Carcangiu ML 2003 Hurthle cell carcinoma: Clinic-pathological and biological aspects. Tumori 89:529-532.
19. Carcangiu ML, Bianchi S, Savino D, Voynick IM, Rosai J1991 Follicular Hurthle cell tumors of the thyroid gland. Cancer 68:1944-1953.
20. Chen H, Nicol TL, Zeiger MA, Dooley WC, Ladenson PW, Cooper DS, Ringel M, Parkerson S, Allo M, Udelsman R 1998 Hurthle cell neoplasms of the thyroid: Are there factors predictive of malignancy? Ann Surg 227:542-546.
21. Udelsman R, Westra WH, Donovan PI, Sohn TA, Cameron JL 2001 Randomized prospective evaluation of frozen-section analysis for follicular neoplasms of the thyroid. Ann Surg 233:716-722.
22. Hay ID, Grant CS, Taylor WF, McConahey WM 1987 Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: A retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 102:1088-1095.
23. Sosa JA, Bowman HM, Tielsch JM, Powe NR, Gordon TA, Udelsman R 1998 The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg 228:320-330.
24. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS 1993 Predicting outcome in papillary thyroid carcinoma: Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114:1050-1057; discussion 1057-1058.
25. Taylor T, Specker B, Robbins J, Sperling M, Ho M, Ain K, Bigos ST, Brierly J, Cooper D, Haugen B, Hay I, Hertzberg V, Klein I, Klein H, Ladenson P, Nishiyama R, Ross D, Sherman S, Maxon HR. 1998 Outcome after treatment of high-risk papillary and non-Hurthle-cell follicular thyroid carcinoma. Ann Intern Med 129:622-627.
26. Wanebo H, Coburn M, Teates D, Cole B 1998 Total thyroidectomy does not enhance disease control or survival even in high-risk patients with differentiated thyroid cancer. Ann Surg 227:912-921.
27. Chen H, Udelsman R 1998 Papillary thyroid carcinoma: Justification for total thyroidectomy and management of lymph node metastases. Surg Oncol Clin North Am 7:645-663.
28. Cady B, Rossi R 1988 An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 104: 947-953.
29. Mazzaferri EL, Jhiang SM 1994 Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418-428.
30. Schlumberger M 1992 Can iodine-131 whole-body scan be replaced by thyroglobulin measurement in the post-surgical follow-up of differentiated thyroid carcinoma? J Nucl Med 33:172-173.
31. Sweeney D, Johnson G 1995 Radioiodine therapy for thyroid cancer. Endocrinol Metab Clin North Am 24:803.
32. Mazzaferri EL, Massoll N 2002 Management of papillary and follicular (differentiated) thyroid cancer: New paradigms using recombinant human thyrotropin. Endocr Relat Cancer 9:227-247.
33. Chin BB, Patel P, Cohade C, Ewertz M, Wahl R, Ladenson P 2004 Recombinant human thyrotropin stimulation of fluoro-D-glucose positron emission tomography uptake in well-differentiated thyroid carcinoma. J Clin Endocrinol Metab 89:91-95.